Involvement of NAD(P)H:Quinone oxidoreductase 1 and superoxide dismutase polymorphisms in ulcerative colitis

DNA and Cell Biology

Volumn 28, Issue 12, 2009, Pages 625-631

  Kosaka, Toshihito ^a   Yoshino, Junji ^a   Inui, Kazuo ^a   Wakabayashi, Takao ^a   Kobayashi, Takashi ^a   Watanabe, Shinya ^a   Hayashi, Shigekazu ^b   Hirokawa, Yoshifumi ^c   Shiraishi, Taizo ^c   Yamamoto, Takayuki ^d   Tsuji, Mayumi ^e   Katoh, Takahiko ^e   Watanabe, Masatoshi ^f  

^a FUJITA HEALTH UNIVERSITY BANTANE HOSPITAL   (Japan)

^b Yachiyo Hospital   (Japan)

^c MIE UNIVERSITY   (Japan)

^d MIE UNIVERSITY   (Japan)

^e KUMAMOTO UNIVERSITY   (Japan)

^f YOKOHAMA NATIONAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); STEROID; SUPEROXIDE DISMUTASE; VALINE;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROCTITIS; RELAPSE; REMISSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ULCERATIVE COLITIS;

ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; NAD(P)H DEHYDROGENASE (QUINONE); POLYMORPHISM, GENETIC; SUPEROXIDE DISMUTASE; YOUNG ADULT;

EID: 72649098994     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2009.0877     Document Type: Article

References (37)

1. Akyol, O., Canatan, H., Yilmaz, H.R., Yuce, H., Ozyurt, H., Sogut, S., Gulec, M., and Elyas, H. (2004). PCR=RFLP-based cost-effective identification of SOD2 signal (leader) sequence polymorphism(Ala-9Val) using NgoM IV: A detailed methodological approach. Clin Chim Acta 245, 151-159.
2. Ambrosone, C.B., Freudebeim, J.L., Thompson, P.A., Bowman, E., Vena, J.E., Marshall, J.R., Graham, S., Laughlin, R., Nemoto, T., and Shields, P.G. (1999). Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res 59, 602-606.
3. Church, S.L., Grant, J.W., Meese, E.U., and Trent, J.M. (1992). Sublocalization of the gene encoding manganese superoxide dismutase (MnSOD=SOD2) to 6q25 by fluorescence in situ hybridization and somatic cell hybrid mapping. Genomics 14, 823-825.
4. Crapo, J.D., Oury, T., Rabouille, C., Slot, J.W., and Chang, L.Y. (1992). Copper, zinc superoxide dismutase is primarily a cytosolic protein in human cells. Proc Natl Acad Sci USA 89, 10405-10409.
5. Daniel, F., Loriot,M.A., Seksik, P.,Cosnes, J.,Gornet, J.M., Lémann, M., Fein, F., Vernier-Massouille, G., De Vos, M., Boureille, A., Treton, X., Flouríe, B., Roblin, X., Louis, E., Zerbib, F., Beaune, P., and Marteau, P. (2007). Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis. Inflamm Bowel Dis 13, 19-23.
6. Esteve, M., and Gisbert, J.P. (2008). Severe ulcerative colitis: At what point should we define resistance to steroids? World J Gastroenterol 14, 5504-5507.
7. Farrell, R.J., and Kelleher, D. (2003). Mechanisms of steroid action and resistance in inflammation. Glucocorticoid resistance in inflammatory bowel disease. J Endocrinol 178, 339-346.
8. Farrell, R.J., Murphy, A., Long, A., Donnelly, S., Cherikuri, A., O'Toole, D., Mahmud, N., Keeling, P.W., Weir, D.G., and Kelleher, D. (2000). High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology 118, 279-288.
9. Guidot, D.M., McCord, J.M., Wright, R.M., and Repine, J.E. (1993). Absence of electron transport (Rho 0 state) restores growth of a manganese-superoxide dismutase-deficient Saccharomyces cerevisiae in hyperoxia: Evidence for electron transport as a major source of superoxide generation in vivo. J Biol Chem 2678, 26699-26703.
10. Hiroi, S., Harada,H., Nishi, H., Sato, M., Nagai, R., and Kimura, A. (1999). Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese. Biochem Biophys Res Commun 261, 332-339.
11. Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H.P., Brockmöller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M., and Brinkmann, U. (2000). Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with Pglycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 97, 3473-3478.
12. Hyde, G.M., and Jewell, D.P. (1997). The management of severe ulcerative colitis. Aliment Pharmacol Ther 11, 419-424.
13. Jaiswal, A.K. (1991). Human NAD(P)H: Quinone oxidoreductase (NQO1) gene structure and induction by dioxin. Biochemistry 30, 10647-10653.
14. Koutroubakis, I.E., Malliaraki, N., Dimoulios, P.D., Karmiris, K., Castanas, E., and Kouroumalis, E.A. (2004). Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease. Dig Dis Sci 49, 1433-1437.
15. Koutroubakis, I., Manousos, O.N., Meuwissen, S.G., and Pena, A.S. (1996). Environmental risk factors in inflammatory bowel disease. Hepatogastroentrerology 43, 381-393.
16. Kruidenier, L., Kuiper, I., Lamers, C.B., and Verspaget, H.W. (2003). Intestinal oxidative damage in inflammatory bowel disease: Semi-quantification, localization, and association with mucosal antioxidants. J Pathol 201, 28-36.
17. Lafuente, M.J., Casterad, X., Trias, M., Ascaso, C., Molina, R., Ballesta, A., Zheng, S., Wiencke, J.K., and Lafuente, A. (2000). NAD(P)H: Quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumor. Carcinogenesis 21, 1813-1819.
18. Larson, R.A., Wang, Y., Banerjee, M., Wiemels, J., Hartford, C., Le Beau, M.M., and Smith, M.T. (1999). Prevalence of the inactivating 609C?T polymorphism in the NAD(P)H: Quinone oxidoreductase gene in patients with primary and therapyrelated myeloid leukemia. Blood 94, 803-807.
19. Marwick, J.A., Ito, K., Adcock, I.M., and Kirkham, P.A. (2007). Oxidative stress and steroid resistance in asthma and COPD: pharmacological manipulation of HDAC-2 as a therapeutic strategy. Expert Opin Ther Targets 11, 745-755.
20. Nakahara, S., Arimura, Y., Saito, K., Goto, A., Motoya, S., Shinomura, Y., Miyamoto, A., and Imai, K. (2008). Association of SLC22A4=5 polymorphisms with steroid responsiveness of inflammatory bowel disease in inflammatory bowel disease in Japan. Dis Col Rec 51, 598-603.
21. Naoe, T., Takeyama, K., Yokozawa, T., Kiyoi, H., Seto, M., Uike, N., Ino, T., Utsunomiya, A., Maruta, A., Jin-nai, I., Kamada, N., Kubota, Y., Nakamura, H., Shimazaki, C., Horiike, S., Kodera, Y., Saito, H.,Ueda, R.,Wiemels, J., andOhno, R. (2000). Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4in 469 Japanesepatientswith therapy-related leukemia= myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res 6, 4091-4095.
22. Newman, B., Gu, X., Wintle, R., Cescon, D., Yazdanpanah, M., Liu, X., Peltekova, V., van Oene, M., Amos, C.I., and Siminovitch, K.A. (2005). A risk haplotype in the Solute Carrier Family 22A4=22A5 gene cluster influences phenotypic expression of Crohn's disease. Gastroenterology 128, 260-269.
23. Olson, S.H., Carlson, M.D., Ostrer, H., Harlap, S., Stone, A., Winters, M., and Ambrosone, C.B. (2004). Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer. Gynecol Oncol 93, 615-620.
24. Orchard, T.R., Satsangi, J., Van Heel, D., and Jewell, D.P. (2000). Genetics of inflammatory bowel disease: A reappraisal. Scand J Immunol 51, 10-17. (Pubitemid 30074297)
25. Phillips, R.M., Basu, S., Brown, J.E., Flannigan, G.M., Loadman, P.M., Martin, S.W., Naylor, B., Puri, R., and Shah, T. (2004). Detection of (NAD(P)H: Quinone oxidoreductase-1, EC1.6.99.2) 609C?T and 459C?T polymorphisms in formalin-fixed, paraffin-embedded human tumour tissue using PCR-RFLP. Int J Oncol 24, 1005-1010.
26. Ross, D., Kepa, J.K., Winski, S.L., Beall, H.D., Anwar, A., and Siegel, D. (2000). NAD(P)H: Quinone oxidoreductase 1 (NQO1): Chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem Biol Interact 129, 77-97.
27. Shimoda-Matsubayashi, S., Matsumine, H., Kobayashi, T., Nakagawa-Hattori, Y., Shimizu, Y., and Mizuno, Y. (1996). Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic in Parkinson's disease. Biochem Biophys Res Commun 226, 561-565.
28. Siegel, D., McGuinness, S.M., Winski, S.L., and Ross, D. (1999). Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H: Quinone oxidoreductase 1. Pharmacogenetics 9, 113-121.
29. Silverberg, M.S., Cho, J.H., Rioux, J.D., McGovern, D.P., Wu, J., Annese, V., Achkar, J.P., Goyette, P., Scott, R., Xu, W., Barmada, M.M., Kiel, L., Daly, M.J., Abraham, C., Bayless, T.M., Bossa, F., Griffiths, A.M., Ippoliti, A.F., Lahaie, R.G., Latiano, A., Paré, P., Proctor, D.D., Regueiro, M.D., Steinhart, A.H., Targan, S.R., Schumm, L.P., Kistner, E.O., Lee, A.T., Gregersen, P.K., Rotter, J.I., Brant, S.R., Taylor, K.D., Roeder, K., and Duerr, R.H. (2009). Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 41, 216-220.
30. Stoehlmacher, J., Ingles, S.A., Park, D.J., Zhang, W., and Lenz, H.J. (2002). The -9Ala=-9Val polymorphism in the mitochondrial targeting sequence of the manganese superoxide dismutase gene (MnSOD) is associated with age among Hispanics with colorectal carcinoma. Oncol Rep 9, 235-238.
31. Sutton, A., Khoury, H., Prip-Buus, C., Cepanec, C., Pessavre, D., and Deqoul, F. (2003). The Ala 16 Val genetic dimorphism modulates the import of human manganese super oxide dismutase in amyotrophic rat liver mitochondria. Pharmacogenetics 13, 145-157.
32. Taufer,M., Peres, A., de Andrade, V.M., de Oliveira, G., Sá, G., do Canto, M.E.P., dos Santos,A.R., Bauer, M.E., and da Cruz, I.B.M. (2005). Is the Val16Ala manganese superoxide dismutase polymorphism with the aging process? J Gerontol 60, 432-438.
33. Traver, R.D., Siegel, D., Beall, H.D., Phillips, R.M., Gibson, N.W., Franklin, W.A., and Ross, D. (1997). Characterization of a polymorphism in NAD(P)H: Quinone oxidoreductase (DTdiaphorase). Br J Cancer 75, 69-75.
34. Travis, S.P., Farrant, J.M., Ricketts, C., Nolan, D.J., Mortensen, N.M., Kettlewell, M.G., and Jewell, D.P. (1996). Predicting outcome in severe ulcerative colitis. Gut 38, 905-910.
35. Truelove, S.C., Willoughby, C.P., Lee, E.G., and Ketlewell, M.G. (1978). Further experience in the treatment in the severe attacks of ulcerative colitis. Lancet 2, 1086-1088.
36. Zelko, I.N., Mariani, T.J., and Folz, R.J. (2002). Superoxide dismutase multigene family: A comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 33, 337-349.
37. Zhang, J.H., Li, Y., Wang, R., Geddert, H., Guo, W., Wen, D.G., Chen, Z.F., Wei, L.Z., Kuang, G., He, M., Zhang, L.W., Wu, M.L., and Wang, S.J. (2003). NQO1C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China. World J Gastroenterol 9, 1390-1393.